NCCN Foundation Awards $1M to Five Early-Career Oncology Researchers
Event summary
- NCCN Foundation awarded five Young Investigator Awards in 2026, each receiving funding for two-year research projects.
- Recipients hail from five leading cancer centers, including Memorial Sloan Kettering and MD Anderson.
- Research focuses on melanoma, pancreatic cancer, AML relapse, breast cancer navigation, and glioblastoma.
- Program marks 15 years of supporting early-career oncology researchers, with past awardees becoming national leaders.
The big picture
The NCCN Foundation's annual awards highlight the critical need to cultivate early-career researchers in oncology, particularly as cancer treatment grows more personalized and complex. With 15 years of program history, this initiative represents a strategic investment in maintaining the pipeline of innovative researchers who will shape future cancer care. The involvement of major pharmaceutical sponsors underscores the industry-wide recognition of this talent development as key to advancing oncology breakthroughs.
What we're watching
- Research Impact
- Whether these projects will produce clinically actionable insights within the two-year funding period.
- Talent Pipeline
- How many past awardees achieve leadership positions in oncology research and policy.
- Industry Collaboration
- The pace at which pharmaceutical sponsors expand their support for early-career investigator programs.
Related topics